Pharma POOL

Seung Baick
James Bruno
Advancis Strengthens Sales and Marketing Capability

Advancis Pharmaceutical has hired Seung Baick as assistant product director, responsible for planning and executing marketing initiatives for the company’s Keflex antibiotic franchise. Advancis, Germantown, Md., is focused on developing and commercializing novel anti-infective products. Mr. Baick most recently was manager, business development and portfolio planning, at Cellective Therapeutics. Additionally, James Bruno has rejoined Advancis as VP of sales. He is responsible for developing the sales and commercialization infrastructure for the Keflex franchise. Mr. Bruno most recently was VP, international marketing, at MedImmune. Dr. R. Alan B. Ezekowitz Merck Appoints Researcher to Key Leadership Role Merck, a global research-driven pharmaceutical company with headquarters in Whitehouse Station, N.J., has appointed R. Alan B. Ezekowitz, MBChB, D.Phil., senior VP and franchise head, immunology, respiratory, and endocrine, at Merck Research Laboratories (MRL). In this newly created position, Dr. Ezekowitz, 52, has overall responsibility for scientific direction across the drug-discovery and development process in these therapeutic areas. He is based at Merck’s research facility in Rahway, N.J. He joins MRL from Massachusetts General Hospital, where he was chief of pediatric services and chair of the executive committee on research. He received his medical training at the University of Cape Town and earned his D.Phil. from the University of Oxford. Dr. Pamela Harris VioQuest Names Chief Medical Officer VioQuest Pharmaceuticals, Basking Ridge, N.J., has named Pamela Harris, M.D., to the role of chief medical officer. VioQuest acquires, develops, and commercializes targeted therapies for oncology, viral, and autoimmune disorders. Most recently, Dr. Harris served as chief medical officer at Callisto Pharmaceuticals. Board certified in internal medicine and medical oncology, she earned her medical degree from the Ohio State University College of Medicine. Gregory Oakes David A. Piacquad Dr. Gregory J. Szpunar Schering-Plough Hires and Promotes Gregory Oakes has been appointed VP of corporate accounts, U.S. managed markets, at Schering-Plough, a global science-based healthcare company based in Kenilworth, N.J. He has been elevated from executive director of corporate accounts. He continues to lead a team of national account managers and has assumed responsibility for the company’s national trade accounts. Mr. Oakes joined Schering-Plough in 1993 as a sales representative. He has a B.S. from Edinboro University and an MBA from Clemson University. David A. Piacquad has been named senior VP, business development, responsible for identifying, analyzing, and pursuing global business development opportunities. He also has been appointed to the Operations Management Team. Previously, Mr. Piacquad held several positions at Johnson & Johnson, most recently VP of ventures and business development. He has a B.A. in philosophy from Colgate University and an MBA in finance from The Wharton School, University of Pennsylvania. Additionally, Gregory J. Szpunar, Ph.D., R.PH., has been appointed group VP, global project management, for the Schering-Plough Research Institute. In this role, Dr. Szpunar is responsible for executing and managing a global project management function for the company’s product development and commercialization process. He comes to Schering-Plough from Biovail, where was chief scientific officer and senior VP for R&D and manufacturing. He has a Ph.D. in pharmaceutics from the University of Michigan, Ann Arbor, and a B.S. in pharmacy from Wayne State University. J. David Owens King Pharmaceuticals Promotes Sales and Marketing Executive King Pharmaceuticals, a branded pharmaceutical company based in Bristol, Tenn., has promoted J. David Owens to senior VP, sales and marketing, hospital division. He is responsible for daily operations and strategic positioning for King’s hospital product line as well as the hospital salesforce and marketing team. Most recently, Mr. Owens was VP for the hospital division. Before joining King in 2004, he was at Aventis Pharma/Rhone-Poulenc Rorer, where he held several executive-level positions including head, global product communications, and VP, cardiology/thrombosis, global marketing and medical affairs group. Mr. Owens, a registered pharmacist, has a bachelor’s degree in pharmacy from the University of Wisconsin. Matthew R. Ruth Avanir Hires VP of Sales Matthew R. Ruth has been named VP of sales at Avanir Pharmaceuticals, San Diego, a company that develops and commercializes novel therapeutic products for the treatment of chronic diseases. In this newly created position, Mr. Ruth is responsible for building, training, and directing Avanir’s sales organization. Most recently, he was the western regional director of sales for Allergan Pharmaceuticals. He has a B.S. from Missouri State University. Biotech POOL Frank D. Czworka Jr. Dr. Allan Darling Dr. Gary B. Ebbert Dr. Bahija Jallal R. Michael Smullen Douglas B. Willner MedImmune Appoints Key Executives MedImmune, Gaithersburg, Md., has promoted Frank D. Czworka Jr. to VP, sales, infectious disease. MedImmune, Gaithersburg, Md., is focused on the areas of infectious disease, cancer, and inflammatory diseases. Mr. Czworka previously was regional business director of MedImmune. In his new position, Mr. Czworka leads salesforce activities for the company’s infectious-disease medicines. Before joining MedImmune in 2000 as an area business manager, he held several positions at TAP Pharmaceuticals. Mr. Czworka has a bachelor of science and arts degree in marketing from the University of Central Florida. MedImmune has hired Allan Darling, Ph.D., as VP, corporate quality control. He oversees quality control at the company’s commercial production facilities in support of antibody, vaccine, and small-molecule manufacturing activities. Previously, Dr. Darling held several positions of increasing responsibility at BioReliance Invitrogen Bioservices, most recently serving as VP, global operations. He has a bachelor’s degree in biological sciences from the University of Edinburgh and a doctorate from the University of Dundee. Gary B. Ebbert, Ph.D., has joined MedImmune as VP, antibody and small-molecule manufacturing, responsible for all antibody and small-molecule commercial manufacturing activities at the company’s production facilities. Dr. Ebbert comes to MedImmune from King Pharmaceuticals, where he was executive VP of worldwide manufacturing. He earned his doctorate in pharmaceutics from Temple University and his master’s degree in biological science, with a concentration in molecular/cell biology, from East Stroudsburg University. Bahija Jallal, Ph.D., has been hired as VP, translational sciences. In this role, Dr. Jallal develops the translational sciences group to assess biomarkers and establish a preclinical knowledge base for MedImmune’s therapeutic agents that will guide clinical studies. She joins MedImmune from Chiron, where she was VP, drug assessment and development. She has a master’s degree in biology from the Universite de Paris VII and a doctorate in physiology from the University of Pierre & Marie Curie. She conducted postdoctoral research at the Max Planck Institute of Biochemistry. MedImmune has promoted R. Michael Smullen to senior VP, sales. In this new role, he has assumed responsibility for sales operations, trade and distribution, managed care and national accounts, and sales training, while continuing to oversee the infectious disease sales team. Before joining MedImmune in 1994 as VP of sales, Mr. Smullen served as national sales director for Synergen. He has a bachelor’s degree from Norwich University. Douglas B. Willner has joined MedImmune as VP, sales training, responsible for building and managing the various sales-training programs. Most recently, Mr. Willner was executive director, learning and organizational excellence, at Serono. He has a B.S. in business and economics from the University of Connecticut. Dr. Deirdre Y. Gillespie Dr. Craig R. Smith La Jolla Pharmaceutical Replaces Key Leaders La Jolla Pharmaceutical has appointed Deirdre Y. Gillespie, M.D., as CEO. San Diego-based La Jolla is a biotechnology company developing therapeutics for antibody-mediated autoimmune diseases. Dr. Gillespie replaces Steven B. Engle, who resigned. Most recently, Dr. Gillespie was the president and CEO of Oxxon Therapeutics. She has an MBA from London Business School and an M.D. and a B.Sc. from London University. La Jolla also has appointed Craig R. Smith, M.D., as chairman of the board. Dr. Smith, who previously served as an independent director, succeeds Stephen M. Martin, who remains on the board. Dr. Smith is currently the president of Williston Consulting, and he previously was chairman, president, and CEO of Guilford Pharmaceuticals. He has an M.D. from the State University of New York at Buffalo. Dr. Roger M. Nocera Medistem Appoints Chief Medical Officer Roger M. Nocera, M.D., has joined Medistem Laboratories as executive VP and chief medical officer. Based in Scottsdale, Ariz., Medistem is a biotechnology company that creates and commercializes advanced medical therapies based on adult stem cells. Dr. Nocera is responsible for interfacing with the company’s international affiliate, the Institute for Cellular Medicines. Board certified in diagnostic radiology and anti-aging medicine, he founded and remains medical director of Arcadia Radiology & Open MRI. He has an M.D. from the University of Massachusetts Medical School. Biopharmaceutical POOL Dr. Michael Adam Anadys Appoints Senior VP, Development Operations Michael Adam, Ph.D., has been named senior VP, development operations, at Anadys Pharmaceuticals, a San Diego-based biopharmaceutical company that discovers, develops, and commercializes small-molecule treatments for hepatitis, other serious infections, and cancer. Dr. Adam is responsible for regulatory affairs, quality assurance, pharmaceutical development, and manufacturing. Most recently he was VP, pharmaceutical sciences, at Pfizer Global Research & Development. He has a Ph.D. in organic chemistry from the Massachusetts Institute of Technology. Paul L. Berns Allos Appoints President and CEO Allos Therapeutics, Westminster, Colo., has named Paul L. Berns president, CEO, and a member of the board of directors. Allos is a biopharmaceutical company focused on developing and commercializing innovative small-molecule therapeutics for the treatment of cancer. Mr. Berns was most recently president, CEO, and a member of the board of directors of Bone Care International. He succeeds Michael E. Hart, who has resigned. Specialty POOL Rob Bancroft Healthpoint Promotes Senior VP, Sales and Marketing Healthpoint, Fort Worth, Texas, a DFB Pharmaceuticals affiliate and a specialty pharmaceutical company, has appointed Rob Bancroft senior VP, sales and marketing, for the company’s tissue management division. In his newly expanded role, Mr. Bancroft has assumed responsibility for the sales and the business intelligence and operations departments. He was most recently VP of marketing, tissue management, a position he held since joining HealthPoint in November 2004. Previously, he was senior marketing director for global Botox at Allergan. Mr. Bancroft has a B.S. in biology from Indiana University and an MBA in marketing and finance from the University of Southern California, Los Angeles. Dr. Bret Berner Depomed Promotes Chief Scientific Officer Bret Berner, Ph.D., has been appointed chief scientific officer at Depomed, Menlo Park, Calif., a specialty pharmaceutical company developing novel oral products and improved formulations of existing oral drugs. Dr. Berner, 53, has assumed this position in addition to his role as VP of product development, which he has held since 1998. Previously, he was VP of development, drug-delivery systems, for Cygnus. He has a Ph.D. in physical chemistry from the University of California, Los Angeles, and a B.A. from the University of Rochester. Greg Gubitz Biovail Changes Organizational Structure Biovail, Mississauga, Ontario, a specialty pharmaceutical company developing pharmaceutical products based on advanced drug-delivery technologies, has reorganized its business and made changes to its executive management team. Greg Gubitz has been named senior VP, Biovail Pharmaceuticals Canada (BPC), formerly Crystaal Pharmaceuticals. He has assumed a leadership role in BPC’s reorganization into a distinct operating unit. For the past three years, Mr. Gubitz was chief operating officer at MDS Capital. William Maichle ProEthic Promotes Senior VP William Maichle has been promoted to senior VP, product development and technical operations, for ProEthic Pharmaceuticals, Montgomery, Ala., a specialty pharmaceutical company that acquires, develops, and markets niche prescription products. Based in the company’s Charlotte, N.C., office, Mr. Maichle oversees all aspects of ProEthic’s branded product development. He previously was the company’s director of product development. Mr. Maichle has a B.S. from Elizabethtown College and undertook his graduate studies at Wake Forest University. Emerging POOL Kurt S. Mussina Aptuit Names VP, Sales and Marketing Kurt S. Mussina has been appointed VP, sales and marketing, for the global drug-development services enterprise of Aptuit, Greenwich, Conn., an emerging company focused on streamlining and supporting the drug-development process. A 19-year industry veteran, Mr. Mussina manages Aptuit’s global sales and marketing force. Most recently, he was VP, commercial operations, for CRF. He has an MBA from the Duke University Fuqua School of Business and a B.S. in chemistry from Montclair State University. Agency POOL Laura Baumann Caroline Baumis Palio Adds Staff Palio Communications has appointed Laura Baumann as account executive. Based in Saratoga Springs, N.Y., Palio is a full-spectrum advertising and communications agency and a subsidiary of inChord Communications, an inVentiv Health company. Ms. Baumann comes to Palio from Integrated Merchandising Systems, where she served as a senior account executive. She has master’s degrees from Loyola University Chicago Graduate School of Business and a bachelor’s degree from The Catholic University of America. Palio also has hired Caroline Baumis as account executive. Ms. Baumis most recently served as a program manager for Gilda’s Club. She has a master’s degree from Fordham University and a bachelor’s degree from New England College. Jeff Chesebro Princeton Partners Hires VP, Group Account Director Jeff Chesebro has joined Princeton Partners as VP, group account director, responsible for directing the business-to-business account management team. Based in Princeton, N.J., Princeton Partners provides integrated brand marketing communication services to consumer, business-to-business, and healthcare clients. Before joining the firm, Mr. Chesebro was senior VP and director of business development at Source Communications. He is a graduate of Miami University. Xio Curry Scientific Advantage Appoints Senior Project Director Xio Curry has been appointed senior project director for Scientific Advantage, Bernardsville, N.J., a provider of services related to medical science liaisons (MSLs). In this role, she directs and coordinates the company’s training workshops and certification programs for MSLs and medical-affairs associates. Ms. Curry previously was the company’s project director. Before joining Scientific Advantage, she was training coordinator at Yamanouchi Pharma America. She is a member of the Healthcare Businesswomen’s Association. Jennifer E. Diskin Tim Fergus Meredith Keroff Beth Lodge Shanna Roehrborn Myra Tejada Charmaine Wilke AbelsonTaylor Builds Staff AbelsonTaylor, Chicago, an independent medical advertising agency, has hired Jennifer E. Diskin as an account supervisor. Previously, she spent three years at CorbettAccel as an account supervisor. Ms. Diskin has a B.A. in communications/ advertising from Purdue University. AbelsonTaylor also has hi ed Tim Fergus as an account supervisor. He comes to the agency from Adair-Greene Healthcare Communications, where he was an account supervisor. He has a B.S. in marketing from Eastern Illinois University. Meredith Keroff has rejoined AbelsonTaylor as an account supervisor. Most recently, she spent two years at CorbettAccel Healthcare as an account supervisor. She has a degree in communications from the University of Kansas. Beth Lodge has been promoted to account supervisor. Ms. Lodge, who has been with AbelsonTaylor for six years, was previously senior account executive. She has a B.S. in marketing from Illinois State University. AbelsonTaylor also has promoted Shanna Roehrborn to account executive. Ms. Roehrborn, who joined the agency in 2002, was previously assistant account executive. She has a B.A. in communication from DePaul University. Myra Tejada also has been promoted to senior account executive, responsible for managing assignments in the diabetes field. Ms. Tejada most recently served AbelsonTaylor as account executive. She joined the agency in 1999 after graduating from the University of Notre Dame with a B.A. in English. AbelsonTaylor has hired Charmaine Wilke as senior account executive. She was previously an account manager at Goble & Associates. She has a B.S. in psychology, premedicine, and marketing from Loyola University of Chicago. D. Stan Fields III Kerry Hurff John Jaeckel GSW Names Executive Staff D. Stan Fields III has been named senior VP/account management at GSW Worldwide, Westerville, Ohio, a part of the inChord Communications division of inVentiv Health and one of the largest healthcare advertising agencies in the world. Mr. Fields has more than 20 years of marketing and advertising experience, most recently as chief operating officer at Leo Burnett Detroit. He has a bachelor’s degree from Michigan State University. Kerry Hurff has been named VP/account director. Most recently, Mr. Hurff served as director of marketing/long term care at Novartis Nutrition. He has a bachelor’s degree from the University of Pennsylvania’s Wharton School. Additionally, John Jaeckel has been appointed VP/creative director. Before joining GSW, Mr. Jaeckel was VP/creative director at Doner Advertising. He has a bachelor’s degree from Knox College. Sheila Gerus Patrick O’Shea Steven Palmisano Interlink Makes Key Staff Moves Interlink Healthcare Communications, Lawrenceville, N.J., has promoted Sheila Gerus to chief strategic officer. Interlink is a full-service healthcare advertising and communications agency. Ms. Gerus is responsible for elevating the agency’s strategic brand insights, attracting and retaining clients, and broadening the agency’s resource pool and services. She has been at Interlink for more than eight years, most recently as VP/management supervisor. She has a degree in pharmacy from the University of Toronto and an MBA from McGill University. Interlink has hired Patrick O’Shea as executive VP/director of client services, responsible for developing the agency’s marketing team talent, overseeing brand-marketing and communication initiatives, and managing all aspects of agency-client interactions. He comes to Interlink from Palio Communications, where he was senior VP/managing director. He holds a degree from Bowling Green State University. Additionally, Steven Palmisano has left his post as senior VP/management supervisor of Interlink to take the helm of IneXel Medical Strategy & Communications, the IHC Group’s new medical education company. As IneXel’s managing director, he is in charge of day-to-day operations. Mr. Palmisano has been with Interlink since 1997. He holds a degree in microbiology and public health from Michigan State University. David Heindl Heather Mauriello MicroMass Expands Client Services Team MicroMass Communications, Cary, N.C., a relationship-marketing agency, has expanded its oncology account services team. David Heindl has been hired as VP, account director, responsible for directing the agency’s largest oncology account. He brings to MicroMass 16 years of industry experience, most recently as account director at Xchange. Heather Mauriello has been named account supervisor. Ms. Mauriello, who has 10 years of agency experience, also joins MicroMass from Xchange, where she was account supervisor. Both Mr. Heindl and Ms. Mauriello are based at the company’s Morristown, N.J., office. Christina Hoffman Columbia MedCom Names VP of Medicalliance Columbia MedCom Group, Columbia, Md., has appointed Christina Hoffman as VP of its wholly owned subsidiary, Medicalliance. She oversees all aspects of client services, operations, and financial performance for the medical marketing services company. Ms. Hoffman most recently was a product manager in the cardiology product and research division of MGI Pharma. She is a member of the Mid-Atlantic chapter of the Healthcare Businesswomen’s Association. Brad Lewis Stonefly Communications Group Names SVP/Client Advisor Stonefly Communications Group, a part of the inChord Communications division of inVentiv Health, has named Brad Lewis to senior VP/client advisor. Based in Westerville, Ohio, Stonefly Communications is a customer-centric healthcare advertising agency. In his new role, Mr. Lewis provides strategic marketing, creative counsel, and guidance to the brand teams of several key healthcare clients. He is based in Massachusetts. Before joining the agency, Mr. Matthews was a consultant for pharmaceutical and biotechnology companies. Kerianne McGuire Beth Paulino CommonHealth Enhances Corporate Communications Department CommonHealth, Parsippany, N.J., a healthcare-communications network and WPP Group company, has hired Kerianne McGuire as manager, corporate communications. In this role, Ms. McGuire writes and distributes press releases, liaises between CommonHealth and media contacts, assists with overall preparation of corporate events, and manages day-to-day projects and activities of the corporate communications department. Most recently, she was an account executive at Patricia Morris Associates. In other CommonHealth news, Beth Paulino has been promoted to senior VP, director of corporate communications. Ms. Paulino continues to manage all organizational public-relations programs, networkwide branding projects, and cross-company events. She also works with cross-CommonHealth teams regarding corporate initiatives. Ms. Paulino has been with the CommonHealth organization for 17 years. For the last seven years, she has been a critical member of the organization’s corporate communications department, spearheading the development of all communications for CommonHealth’s 13 individual business units. Ted Newland Edward Newland Associates Names President Edward Newland Associates (ENA), a full-service medical communications company based in Tinton Falls, N.J., has promoted Ted Newland to president and chief operating officer. He is charged with overseeing business growth while maintaining its reputation of high-quality work, customer service, and talented employees. Mr. Newland most recently served as the firm’s executive VP. Before joining ENA in 1993, he worked for Clark O’Neill (now Synavant). He has a B.S. in economics from Syracuse University. He also completed the Healthcare Marketing and Communications Council’s Pharmaceutical Advertising Program as well as the Advanced Seminar for Healthcare Marketing Executives at Dartmouth College. Kathie Coe Renner Seidler Bernstein Appoints Creative Director Seidler Bernstein, a full-service marketing and communications agency based in Cambridge, Mass., has named Kathie Coe Renner executive creative director. Ms. Renner joins Seidler Bernstein after a successful freelance career working with small to mid-size companies, advertising agencies, and nonprofits. She has a bachelor of fine arts degree in communications design from the Massachusetts College of Art. Mike Weiss /alert Promotes Sales Leader Mike Weiss has been promoted to VP, sales, at /alert Marketing, Santa Clara, Calif., a division of Jobson Publishing Group that provides media for delivery of healthcare information and education to professionals and consumers. In his new role, Mr. Weiss leads and directs the sales team. He originally joined /alert in January 2004 as national sales manager. Mr. Weiss previously had extensive experience with Roche Laboratories in sales, sales training, sales management, market research, and marketing. Consulting POOL Dr. Judith Atkins Mark Lookabaugh Firoz Nilam Dr. Irach Taraporewala Parexel Appoints Senior-Level Consultants Parexel Consulting, Waltham, Mass., a global life-sciences consultancy serving the biopharmaceutical and medical-device industries, has hired Judith Atkins, Ph.D., as a senior consultant. Previously, Dr. Atkins held director of regulatory affairs positions at Amgen Canada and Sanofi Pasteur (formerly Aventis Pasteur). She has a Ph.D. in biochemistry and a fellowship degree from the Ontario Cancer Institute. Mark Lookabaugh also has joined Parexel as a senior consultant, providing Good Manufacturing Practice (GMP) and Quality System Regulation (QSR) auditing and consulting services to clients worldwide. Mr. Lookabaugh previously spent 30 years with the U.S. Food and Drug Administration (FDA), where he most recently was director, compliance branch. Firoz Nilam has been appointed as a VP at Parexel. He brings 30 years of experience in the pharmaceutical and biotechnology industries, including management of global departments with staff located in the United States, Europe, and Japan. He has postgraduate and undergraduate degrees in biochemistry and chemistry. Irach Taraporewala, Ph.D., has joined Parexel as a senior consultant, responsible for advising companies on drug candidate selection and optimization, GMP, Good Laboratory Practice (GLP), pre-investigational new drug submissions, strategic planning for regulatory submissions, and intellectual property matters. Dr. Taraporewala brings to Parexel more than 20 years of experience in the areas of manufacturing and control. He holds a Ph.D. in medicinal chemistry from the Philadelphia College of Pharmacy and Science. Dr. Brad Davidson MBS/Vox Promotes VP Brad Davidson, Ph.D., has been promoted to VP, account group director for MBS/Vox, Parsippany, N.J., CommonHealth’s research-based consultancy unit specializing in the analysis of physician-patient communication. In his new role, Dr. Davidson directs research projects, publishes and presents study results, and works collaboratively across all disciplines at CommonHealth. He came to MBS/Vox two years ago from Lexicon Branding, where he was a principal researcher. He has a doctorate in linguistics from Stanford University. CRO POOL Sarah Beeby Dr. Dennis Hurley Kendle Names Leaders of New Operating Units Kendle, a global, full-service clinical research organization (CRO) based in Cincinnati, has appointed Sarah Beeby, VP, global clinical development — Asia/Pacific. She oversees the company’s new operating unit focused on providing Phase I-III services in this region. Ms. Beeby originally came to Kendle in 2001 as assistant director of clinical services. Most recently, she served as director, strategic business services, Europe. She has a B.S. in animal physiology from Queen Mary & Westfield College, University of London. Additionally, Dennis Hurley, Dr.Sc., has been appointed VP, global clinical development — Latin America. He oversees Kendle’s new Phase I-III unit in that region. Dr. Hurley joined Kendle in 2003 as VP, Latin America, in conjunction with the company’s acquisition of Estadísticos y Clínicos Asociados (ECA), of which he was cofounder. He completed a postdoctorate in biostatistics at the University of North Carolina at Chapel Hill. Patrick Jackle Pacific Biometrics Names Business Development Manager Pacific Biometrics, a Seattle-based provider of specialized central laboratory and contract research services, has hired Patrick Jackle as business development manager. In this role, Mr. Jackle helps promote and maintain Pacific Biometrics’ collaborative and business relationships with diagnostic, pharmaceutical, and biotech companies. Most recently, Mr. Jackle was district manager of Novartis Pharmaceuticals. He has a B.S. from California State Polytechnic University. Medical-Education POOL Lisa S. Berger Monica Bhatia MaryAnn McAdams Shannon McCarney HLS Hires and Promotes Health Learning Systems (HLS), Parsippany, N.J., the medical-education unit of CommonHealth, has hired Lisa S. Berger as VP, professional relations. Ms. Berger is responsible for maintaining and developing client relationships, expanding the group’s client base, and actively participating in new business development. Most recently, she held an account management/new business development position at J.L. Shapiro Associates. Monica Bhatia also has joined HLS as a program director, responsible for managing the planning and execution of a variety of healthcare-communications and medical-education initiatives. Ms. Bhatia previously was director of continuing medical education at the Ochsner Clinic Foundation. MaryAnn McAdams has been promoted to manager, editorial department. In this position, she is charged with directing a full-service editorial department and managing the overall workflow of the department. Ms. McAdams, who has been with HLS for three years, previously served as senior editor. HLS has hired Shannon McCarney as a program coordinator. In this role, Ms. McCarney serves as liaison between multiple departments, ensuring timely completion of projects. She previously was an administrative assistant at Automated Data Processing. Glenn Kapuscienski MediMedia Hires Sales VP MediMedia Educational Group, Chatham, N.J., a MediMedia USA company that specializes in thought-leader development and educational activities, has appointed Glenn Kapuscienski, as VP, sales. He is responsible for creating and selling special projects to new and existing clients. Mr. Kapuscienski most recently was VP and general manager for Liberty Communications, a division of Cardinal Health. Lawrence Sherman Physicians Academy Appoints CEO Lawrence Sherman has been named CEO of The Physicians Academy for Clinical and Management Excellence, New York, a full-service provider of medical-education solutions. Along with ensuring the appropriate delivery of the organization’s educational activities, Mr. Sherman also helps to forge and strengthen partnerships with organizations requiring continuing medical education or continuing professional development certification. Mr. Sherman previously was president of Jobson Education. Shawn Whalen Shinn CBCE Names Senior VP The Center for Biomedical Continuing Education (CBCE), Irving, Texas, a division of inVentiv Health and an accredited provider of continuing medical education programs for healthcare professionals, has named Shawn Whalen Shinn senior VP. Ms. Shinn is responsible for growing the continuing medical education business and expanding it into new therapeutic areas with innovative educational models. Previously, she served as VP and general manager at Trinity Workplace Learning, formerly Primedia. She has a bachelor’s degree from Arizona State University. Anita St. Clair HealthEd Strengthens Leadership HealthEd has appointed Anita St. Clair as senior VP and management supervisor, responsible for managing account relationships and overall project supervision for clients. Based in Clark, N.J., HealthEd develops patient-education programs for pharmaceutical and healthcare marketers. Ms. St. Clair brings to HealthEd more than a decade of agency experience. Most recently, she was a senior VP and management supervisor at CommonHealth. Dr. David St. Peter The Selva Group Promotes Managing Director The Selva Group, a subsidiary of inChord Communications, an inVentiv Health company, has promoted David St. Peter, M.D., to executive VP and managing director. Selva is a full-service medical-education and event-management company based in Saratoga Springs, N.Y. He most recently was senior VP/medical director of Palio Communications’ medical strategies group as well as the agency’s event-marketing and educational services. Under his direction, this practice group later became The Selva Group, a sister company to Palio. Before joining Palio in 2001, Dr. St. Peter was in private practice. He holds an M.D. from Kansas University Medical Center and a bachelor’s degree from the University of Kansas. Service POOL Tyrone Brewer Jackie Gerber Tricia Glover Bob Melillo Joe Melillo inVentiv Commercial Adds Staff Tyrone Brewer has joined the patient-services team of inVentiv Commercial Services, Somerset, N.J., as executive director, marketing/business development. inVentiv Commercial, a division of inVentiv Health, provides integrated services to support clients in launching and maintaining their products in the healthcare market. Mr. Brewer brings a strong background in pharmaceutical sales, marketing, and product management with leadership experience in nephrology, respiratory, and anti-infectives. Previously, he held senior-level marketing positions within Ortho Biotech and Sanofi-Aventis. Jackie Gerber also has joined inVentiv Commercial as director of regulatory compliance. In this role, she addresses the day-to-day sampling regulatory issues, both internally and externally. Tricia Glover has been appointed chief compliance officer. She helps the company continue to identify ways to more effectively manage business as well as offer processes and programs that comply to PDMA and OIG guidelines. Ms. Glover also serves as VP and managing director of OIG compliance, audits, and inventories, for inVentiv Pharma Services. Previously, Ms. Glover held compliance-management positions at Teva Neuroscience, Sanofi-Aventis, and Pfizer. Bob Melillo has joined inVentiv Commerical as VP and managing director of sample management. In this role, he is responsible for The Franklin Group and PRS Sample Accountability businesses as well as for coordinating the company’s whole-system sample management offering. Mr. Melillo previously was a principal at PRS (Pharmaceutical Resource Solutions), which inVentiv acquired in August 2005. Joe Melillo also has come to inVentiv Commercial from PRS. He serves as VP, operations, sample management. David R. Carlucci IMS Names Top Executive David R. Carlucci, CEO, and president of IMS Health, Fairfield, Conn., a provider of market intelligence to the pharmaceutical and healthcare industries, has been appointed to the additional role of chairman. Mr. Carlucci succeeds David M. Thomas as the company’s chairman. Mr. Thomas, 56, has retired from the IMS board of directors after more than five years of leadership. Mr. Carlucci, 51, joined IMS in 2002 after a 26-year career at IBM, where he most recently was general manager, IBM Americas. He holds a B.A. in political science from the University of Rochester. Alan Horgan Octagon Appoints Chief Operating Officer Octagon Research Solutions, Wayne, Pa., a process-centric solutions provider, has appointed Alan Horgan to the newly created post of chief operating officer. A 25-year veteran of the pharma industry, Mr. Horgan most recently was group VP, late-stage development, at MDS Pharma Services. Lawrence D. Poster DHR Hires Executive VP DHR International, a Chicago-based executive search firm, has hired Lawrence D. Poster as executive VP in the agency’s New York office. He is also a member of the firm’s Life Sciences Practice. Mr. Poster joins DHR International from Catalyx Group/Executive Search, which he founded in 1987. He has a bachelor’s degree in management science from the Massachusetts Institute of Technology. Stacy Traub PreferredTime Appoints Sales Director Stacy Traub has been named director of sales at PreferredTime, a Boston-based company offering a pharmaceutical rep coordination service. In this role, Ms. Traub directs and oversees the company’s national sales efforts. Before joining PreferredTime, she was program director for Raytel Cardiac Services. She has B.S. in business administration from Ithaca College. Dr. J. Jay Volkert Lincoln Technologies Appoints Manager, Government Sector J. Jay Volkert, Ph.D., has been named manager, government sector, for Lincoln Technologies, Waltham, Mass., a Phase Forward company that delivers solutions for pharmacovigilance, data standardization, and safety-signal detection. Dr. Volkert joins Lincoln Technologies from The Lewin Group, where he was VP for healthcare policy. He holds a Ph.D. in public administration from The American University, a master’s degree from The University of Wisconsin, Madison, and a bachelor’s degree from Purdue University. Eric Zoetmulder SciQuest Hires Director of Supplier Enablement SciQuest, Cary, N.C., has hired Eric Zoetmulder as director of supplier enablement. SciQuest provides on-demand supplier management and procurement automation solutions. Previously, Mr. Zoetmulder was the senior director of information systems and editorial processes for Thomson — Dialog. He has a master’s of science in information technology from Delft University of Technology. Technology/Web POOL Stuart Davie Aegis Appoints Chief Technology Officer Stuart Davie has been named chief technology officer of Aegis Analytical, Lafayette, Colo., a provider of software solutions and services for life-sciences manufacturers. In this role, he leads the company’s product engineering and technology development efforts. Mr. Davie has more than 20 years of senior management experience in IT management. Most recently, he was chief information officer for Novartis’ Sandoz division. Bryan Lilley AHM Promotes VP, Software Development Bryan Lilley has been promoted to VP of software development at Advanced Health Media (AHM), Union, N.J., a supplier of technology solutions for compliant pharmaceutical meetings, speaker programs, and healthcare-professional interactions. In this role, Mr. Lilley oversees AHM’s software development organization based in Chesapeake, Va. Previously, he was the firm’s director of software development. He has a B.A. in computer information systems from James Madison University. LaVonne Reimer Compiere Appoints CEO LaVonne Reimer has been named CEO of Compiere, Portland, Ore., a provider of open-source enterprise resource planning and customer relationship management applications. Ms. Reimer is working to accelerate the company’s growth and expand its global partnerships. Most recently, Ms. Reimer created the Open Technology Business Center. John Tondra Invivodata Appoints VP of Worldwide Operations John Tondra has joined Invivodata in the newly created position of VP, worldwide operations. Invivodata, Pittsburgh, Pa., offers solutions for capturing high-quality electronic patient-reported outcome (ePRO) data. Mr. Tondra manages the company’s electronic handheld and site-based PRO-data collection systems in worldwide clinical trials. Most recently, Mr. Tondra was director of worldwide operations for Pinnacle Systems Please send your personnel announcements to [email protected].

Download PDF